Watervliet, NY, United States of America

Wei Xue

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Xue. Retrieved from https://idiyas.com/inventor/wei-xue-9osicpd4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wei Xue: Innovator in Cell Culture Technology

Introduction

Wei Xue is a prominent inventor based in Watervliet, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of cell culture media for eukaryotic cells. With a total of 4 patents to his name, Wei Xue is recognized for his innovative approaches to enhancing cell culture techniques.

Latest Patents

Wei Xue's latest patents focus on the formulation of cell culture media designed specifically for eukaryotic cells. These patents detail methods for using the media to optimize cell culture and improve protein production from cells. His work in this area is crucial for advancements in biopharmaceuticals and research applications.

Career Highlights

Wei Xue is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative therapies. His role at Regeneron allows him to apply his expertise in cell culture technology to real-world challenges in drug development and production.

Collaborations

Throughout his career, Wei has collaborated with notable colleagues, including John Chen and Carolyn Scott. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their shared field.

Conclusion

Wei Xue's contributions to cell culture technology exemplify the impact of innovative thinking in biotechnology. His patents and work at Regeneron Pharmaceuticals, Inc. continue to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…